FA2G1 Glycan (G1F), Procainamide labelled [Labeled Glycan Standards] (CAT#: CB-P417-K) Datasheet

Product Type
Glycan Standards
Description
A toothless biantennary compound N-glycan (oligosaccharide) with a galactose on both ends of the antennae. The glycan is a mixture of two possible galactosylated isomers.
Features
Synonyms: FA2G1 N-linked oligosaccharide.
Sources: FA2G1 glycan is found on several mammalian glycoproteins including asialo serum transferrin and fibrin. This product is typically purified from the oligosaccharide pool released from bovine serum by hydrazinolysis using HPLC.
Form: Dry. Dried by centrifugal evaporation from an aqueous solution.
Molecular Weight: 1624.6 g/mol
Purity:> 90% pure as assessed by a combination of 1 H-NMR and HPAE-PAD.
Sample
Glycoproteins and glycopeptides containing N-linked glycans
Handling Advice
Allow the unopened vial to reach ambient temperature and tap unopened on a solid surface to ensure that most of the lyophilized material is at the bottom of the vial. Gently remove the cap, add the desired volume of reconstitution medium, re-cap and mix thoroughly to bring all the oligosaccharide into solution. For maximal recovery of oligosaccharide, ensure that the cap lining is also rinsed and centrifuge the reconstituted vial briefly before use. Ensure that any glass, plasticware or solvents used are free of glycosidases and environmental carbohydrates.
Storage
Refridgerate (-20°C) both before and after dissolution. This product is stable for at least 5 years as supplied.
Shelf Life
Stability: Stable at least 12 months when stored properly. Several days exposure to ambient tempertures will not reduce activity.
Research Use
For research use only. Not for human or drug use

Figure 1 Structure

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK